Clinical Trial Update: Postoperative aRCH With Cisplatin Versus aRCH With Cisplatin and Pembrolizumab in Locally Advanced Head and Neck Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing postoperative adjuvant radiochemotherapy with cisplatin alone versus cisplatin plus pembrolizumab in locally advanced head and neck sq…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: University of Leipzig | Conditions: HNSCC | Phase 2 | Status: COMPLETED